Lexston Life Sciences Corp. (LEXTF)
USD 0.17
(0.0%)
USD 0.17
(0.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 | 750.94 Thousand CAD | -7.78% |
| 2023 | 814.3 Thousand CAD | -14.54% |
| 2022 | 952.79 Thousand CAD | -13.6% |
| 2021 | 1.1 Million CAD | 545.11% |
| 2020 | 170.95 Thousand USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 576.16 Thousand CAD | -19.11% |
| 2024 Q4 | 750.94 Thousand CAD | 57.79% |
| 2024 Q3 | 475.91 Thousand CAD | -17.4% |
| 2024 Q1 | 712.28 Thousand CAD | -12.53% |
| 2023 Q2 | 1.2 Million CAD | -22.08% |
| 2023 Q1 | 1.54 Million CAD | 61.75% |
| 2023 Q4 | 814.3 Thousand CAD | -9.13% |
| 2023 FY | 814.3 Thousand CAD | -14.54% |
| 2023 Q3 | 896.13 Thousand CAD | -25.37% |
| 2022 FY | 952.79 Thousand CAD | -13.6% |
| 2022 Q3 | 1.63 Million CAD | -10.27% |
| 2022 Q2 | 1.82 Million CAD | 55.69% |
| 2022 Q1 | 1.17 Million CAD | 0.0% |
| 2022 Q4 | 952.79 Thousand CAD | -41.76% |
| 2021 Q2 | 1.13 Million USD | 0.0% |
| 2021 FY | 1.1 Million CAD | 545.11% |
| 2020 FY | 170.95 Thousand USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Qrons Inc. | 420.00 USD | -178697.381% |
| Santhera Pharmaceuticals Holding AG | 130.21 Million USD | 99.423% |
| Nascent Biotech, Inc. | 552.12 Thousand USD | -36.012% |
| Adynxx, Inc. | - USD | -Infinity% |
| Acro Biomedical Co., Ltd. | 687.48 Thousand USD | -9.231% |
| Capstone Therapeutics Corp. | 52.7 Million USD | 98.575% |
| BioStem Technologies, Inc. | 14.56 Million USD | 94.842% |
| CSL Limited | 38.02 Billion USD | 99.998% |
| Arch Therapeutics, Inc. | 1.95 Million USD | 61.651% |
| Evofem Biosciences, Inc. | 10.55 Million USD | 92.885% |
| Northwest Biotherapeutics, Inc. | 27.94 Million USD | 97.313% |
| Regen BioPharma, Inc. | 353.61 Thousand USD | -112.362% |
| Skye Bioscience, Inc. | 11.94 Million USD | 93.711% |
| ProtoKinetix, Incorporated | 480.55 Thousand USD | -56.266% |
| Rebus Holdings, Inc. | 5000.00 USD | -14918.98% |
| Burzynski Research Institute, Inc. | 2310.00 USD | -32408.615% |
| Neon Bloom, Inc. | 770.64 Thousand USD | 2.556% |
| Eiger BioPharmaceuticals, Inc. | 38.84 Million USD | 98.067% |
| Nanobac Pharmaceuticals, Incorporated | 7.21 Million USD | 89.599% |
| Institute of Biomedical Research Corp. | 76.35 Thousand USD | -883.51% |
| SQZ Biotechnologies Company | 107.18 Million USD | 99.299% |
| Intellipharmaceutics International Inc. | 1.43 Million USD | 47.561% |
| Propanc Biopharma, Inc. | 72.36 Thousand USD | -937.724% |
| Mesoblast Limited | 667.9 Million USD | 99.888% |
| Marizyme, Inc. | 22.01 Million USD | 96.589% |
| Genus plc | 1.02 Billion USD | 99.927% |
| VioQuest Pharmaceuticals, Inc. | 1.35 Million USD | 44.716% |
| Pharming Group N.V. | 462.85 Million USD | 99.838% |
| Therapeutic Solutions International, Inc. | 3.31 Million USD | 77.333% |
| CNBX Pharmaceuticals Inc. | 499.03 Thousand USD | -50.479% |
| Nymox Pharmaceutical Corporation | 627 Thousand USD | -19.769% |
| ContraFect Corporation | 20.67 Million USD | 96.369% |
| PsyBio Therapeutics Corp. | 390.36 Thousand USD | -92.37% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 382.17 Thousand USD | -96.492% |
| IMV Inc. | 31.33 Million USD | 97.603% |
| AXIM Biotechnologies, Inc. | 4.14 Million USD | 81.887% |
| MultiCell Technologies, Inc. | 126.22 USD | -594852.464% |
| ONE Bio Corp. | 70.08 Million USD | 98.929% |
| Accustem Sciences Inc. | 939.68 Thousand USD | 20.085% |
| RVL Pharmaceuticals plc | 128.51 Million USD | 99.416% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| EV Biologics, Inc. | 431.71 Thousand USD | -73.946% |
| Q BioMed Inc. | 3.51 Million USD | 78.639% |
| Emmaus Life Sciences, Inc. | 35.17 Million USD | 97.865% |
| Mosaic ImmunoEngineering Inc. | 261.27 Thousand USD | -187.415% |
| Biomind Labs Inc. | 73.81 Thousand USD | -917.284% |
| American Oriental Bioengineering, Inc. | 446.3 Million USD | 99.832% |
| Provectus Biopharmaceuticals, Inc. | 1.44 Million USD | 48.169% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Oncotelic Therapeutics, Inc. | 30.01 Million USD | 97.498% |
| GlobeStar Therapeutics Corporation | - USD | -Infinity% |
| THC Farmaceuticals, Inc. | 2.74 Million USD | 72.656% |
| Curative Biotechnology, Inc. | 2.6 Million USD | 71.153% |
| GB Sciences, Inc. | 103.44 Thousand USD | -625.961% |
| Alpha Cognition Inc. | 2.45 Million USD | 69.376% |
| HST Global, Inc. | 1526.00 USD | -49110.288% |
| Wesana Health Holdings Inc. | 987.96 Thousand USD | 23.99% |
| Halberd Corporation | 10.13 Thousand USD | -7312.388% |
| Enzolytics Inc. | 361.7 Million USD | 99.792% |
| Agentix Corp. | 261.39 Thousand USD | -187.288% |
| Resverlogix Corp. | 8.11 Million USD | 90.746% |
| Nuo Therapeutics, Inc. | 1.87 Million USD | 60.011% |
| MetaStat, Inc. | - USD | -Infinity% |
| argenx SE | 4.54 Billion USD | 99.983% |
| Enzon Pharmaceuticals, Inc. | 47.7 Million USD | 98.426% |
| Endonovo Therapeutics, Inc. | 639.65 Thousand USD | -17.399% |
| RespireRx Pharmaceuticals Inc. | 22.78 Thousand USD | -3196.383% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | 8.94 Million USD | 91.609% |
| AVAX Technologies, Inc. | 7.37 Million USD | 89.821% |
| Zenith Capital Corp. | 7410.00 USD | -10034.265% |
| Genscript Biotech Corporation | 3.38 Billion USD | 99.978% |
| Ember Therapeutics, Inc. | 184.00 USD | -408024.457% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 321.8 Thousand USD | -133.355% |
| WPD Pharmaceuticals Inc. | 261.36 Thousand USD | -187.319% |
| Cotinga Pharmaceuticals Inc. | 927.96 Thousand USD | 19.075% |
| Kadimastem Ltd | 2.3 Million USD | 67.408% |
| Helix BioMedix, Inc. | 3.02 Million USD | 75.176% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Reve Technologies, Inc. | 57.09 Thousand USD | -1215.285% |
| LadRx Corporation | 2.3 Million USD | 67.462% |
| Cell Source, Inc. | 195.17 Thousand USD | -284.765% |
| Regen BioPharma, Inc. | 353.61 Thousand USD | -112.362% |
| NovAccess Global Inc. | 62.24 Thousand USD | -1106.383% |
| Affymax, Inc. | 7.44 Million USD | 89.911% |
| Itoco Inc. | 1.4 Million USD | 46.364% |
| Rasna Therapeutics, Inc. | 95.65 Thousand USD | -685.043% |
| Pathfinder Cell Therapy, Inc. | 106 Thousand USD | -608.442% |
| Mobile Lads Corp. | 52.00 USD | -1444032.692% |
| CytoDyn Inc. | 11.13 Million USD | 93.257% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | 142.97 Thousand USD | -425.242% |
| NanoSphere Health Sciences Inc. | 17.88 Thousand USD | -4099.938% |
| Alseres Pharmaceuticals, Inc. | 385.47 Thousand USD | -94.813% |
| SYBLEU INC | 330.46 Thousand USD | -127.238% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| ImmunoCellular Therapeutics, Ltd. | 409.42 Thousand USD | -83.417% |
| International Stem Cell Corporation | 5.39 Million USD | 86.068% |
| Bioxytran, Inc. | 137.63 Thousand USD | -445.597% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | 15 Million USD | 94.994% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | - USD | -Infinity% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 16.57 Million USD | 95.47% |
| Adhera Therapeutics, Inc. | 79 Thousand USD | -850.568% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | 864.67 Thousand USD | 13.153% |
| Innovation Pharmaceuticals Inc. | 7.51 Million USD | 90.01% |
| Neutra Corp. | 2851.00 USD | -26239.846% |
| Windtree Therapeutics, Inc. | 32.4 Million USD | 97.683% |
| PureTech Health plc | 693.97 Million USD | 99.892% |
| Coeptis Therapeutics, Inc. | 8.07 Million USD | 90.696% |
| IXICO plc | 15.84 Million USD | 95.26% |
| IntelGenx Technologies Corp. | 8.28 Million USD | 90.933% |
| Gelesis Holdings, Inc. | 103.32 Million USD | 99.273% |
| CSL Limited | 38.02 Billion USD | 99.998% |
| Cellectis S.A. | 333.99 Million USD | 99.775% |